A Simple Blood Test Could Transform Alzheimer's Diagnosis

For decades, diagnosing Alzheimer's disease has relied heavily on memory tests, clinical judgment, and a long wait for symptoms to become unmistakable. Now, a groundbreaking blood test being rolled out across the UK could dramatically change that narrative bringing earlier, more accurate diagnosis within reach of routine healthcare.

- 

More than 1,000 people with suspected dementia are set to receive the new test as part of a major NHS-linked trial led by scientists at University College London (UCL). If successful, the approach could revolutionise how Alzheimer's disease is identified, offering clarity to patients years earlier than was previously possible.

Why Early Diagnosis Matters

Alzheimer's disease, the most common form of dementia, is driven by the gradual accumulation of two abnormal proteins in the brain amyloid and tau. These so-called “rogue proteins” can begin building up as much as 20 years before symptoms appear, silently damaging brain cells long before memory problems become obvious.